Skip to main content

COVID variant Archives

Update on COVID-19 for VUMC workforce: what you need to know

Jul. 19, 2021—COVID-19 is still very much part of our daily lives, and infection rates are on the increase in the community. VUMC continues to effectively manage COVID-19, and outpatient and inpatient volumes are back to pre-COVID levels.

Read more


Statement from VUMC: COVID-19 vaccination continues to be the way forward

Jul. 19, 2021—Last week, Vanderbilt University Medical Center announced that COVID-19 vaccinations for leaders will become mandatory. This was a carefully considered step forward in VUMC’s ongoing efforts to protect its patients and employees from the SARS-CoV-2 virus and its variants.

Read more


Combination antibody therapies should retain effectiveness against emerging COVID-19 variants: study

Jun. 22, 2021—Five monoclonal antibody “cocktails,” including one developed at Vanderbilt University Medical Center (VUMC), are protective in animal studies against several variant strains of COVID-19, according to a report this week in the journal Nature.

Read more


VUMC team screens high school for SARS-CoV-2 asymptomatic infections

Apr. 29, 2021—Under the SARS CoV-2 Return to School Saliva Opt-in Screening Study, which began last November at University School of Nashville, a research team from Vanderbilt University Medical Center is testing a solution for efficient asymptomatic disease surveillance and control.

Read more


Investigational vaccine to be tested against COVID-19 variant

Apr. 2, 2021—Vanderbilt University Medical Center is participating in a national phase 1 clinical trial in healthy adults of an investigational vaccine against the B.1.351 variant of the COVID-19 virus that was first identified in South Africa.

Read more


Recent Stories from VUMC News and Communications Publications

Vanderbilt Medicine
Hope
Momentum
VUMC Voice

more